Back to 
LOS ANGELES CAPITAL MANAGEMENT LLC
LOS ANGELES CAPITAL MANAGEMENT LLC
VIVO
Showing 0 of 14 quarters
Position history for LOS ANGELES CAPITAL MANAGEMENT LLC's holdings in MERIDIAN BIOSCIENCE INC
No. Los Angeles Capital Management exited its VIVO (Meridian Bioscience) position in Q3 2022. Its Q2 2022 13F listed 16,034 shares worth $488,000. Los Angeles Capital Management already held VIVO in its Q4 2018 13F, the earliest on record, and held it in 12 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.